Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder
DOI: 10.1001/jamapsychiatry.2026.1092Author: Masoumeh Amin-Esmaeili et al.Published: 2026-8-1

Forum › Forums › Available Download: › DOI › Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder

DOI: 10.1001/jamapsychiatry.2026.1092Author: Masoumeh Amin-Esmaeili et al.Published: 2026-8-1

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • June 7, 2026 at 2:45 pm #1799
    aggelnovaaggelnova
    Participant

    Title: Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder
    Journal: JAMA Psychiatry
    Authors: Masoumeh Amin-Esmaeili, Mehdi Farokhnia, Ramin Mojtabai, Lorenzo Leggio, Renee M. Johnson, Ryoko Susukida
    Date: 2026-6-3
    DOI: 10.1001/jamapsychiatry.2026.1092
    Source: American Medical Association (AMA)
    Source URL: https://doi.org/10.1001/jamapsychiatry.2026.1092

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.